Navigation Links
Positive Results From Avanafil Post-Prostatectomy Study Featured at Cancer Survivorship Meeting
Date:6/17/2011

erience.

About the Avanafil Phase 3 ProgramThe avanafil phase 3 program consists of three studies: TA-301 (REVIVE), TA-302 (REVIVE-Diabetes), and TA-303 (REVIVE-RP) and a 52-week, open-label, long-term safety study (TA-314). TA-301, TA-302 and TA-303 were all randomized, double-blind, placebo-controlled phase 3 studies of avanafil in 646, 390, and 298 men respectively with a history of ED for at least six months.  Each of the pivotal trials had a similar trial design with patients undergoing a four-week, non-treatment run-in period followed by 12 weeks of treatment. Primary endpoints of the studies were improvement in erectile function as measured by the Sexual Encounter Profile (SEP) and improvements in the EF domain score of the International Index of Erectile Function (IIEF). In all three studies, all doses of avanafil tested met the primary endpoints, with successful intercourse achieved by some subjects in 15 minutes or less after administration.  

TA-314 evaluated avanafil for up to 52-weeks in 712 men, 486 with a history of ED and 226 diabetic men with ED across 40 centers throughout the U.S.  Patients completing REVIVE (TA-301) or REVIVE-Diabetes (TA-302) were eligible for rollover into TA-314.  The study met all primary endpoints by demonstrating sustained improvement from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP 2 and SEP 3) and improvements in the International Index of Erectile Function (IIEF).  The study also indicated a favorable side effect profile and successful intercourse (as measured by SEP 3) in as little as 15 minutes and beyond six hours after dosing, without any restrictions on food or alcohol intake.

VIVUS held a pre-NDA meeting with the FDA to confirm that the pre-clinical and clinical requirements necessary for the filing of an NDA have been met. In total, the phase 3 avanafil clinical program enrolled approximately 1,350 subjects. VIVUS
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
2. Dong-A PharmTech Co., Ltd. and Dr. Falk Pharma GmbH Announce Positive Data in Portal Hypertension With Udenafil
3. BioSpecifics Announces Positive XIAPEX® Data Presented at XVI Annual Federation of European Societies for Surgery of the Hand Congress
4. Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients
5. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
6. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
7. KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP201 for Pain
8. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
9. Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting
10. Positive Results Reported for Phase II Randomized Double-Blind Clinical Trial for the Treatment of Drug-Resistant Epilepsy Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
11. Reportlinker Adds Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  A Boston Scientific Corporation (NYSE: ... removability and preliminary long term stricture resolution of ... August issue of the peer-reviewed journal, Gastroenterology. ... being conducted in 11 countries and five continents, ... stents (FCSEMS) after extended indwell (i.e., up to ...
(Date:8/29/2014)... 29, 2014 Medina Medical announced today that ... of the Board of Directors on August 18, 2014. ... and commercialization experience, including over a decade of direct ... as a Partner of the medical device incubator The ... two Foundry start-ups. Mr. Engelson previously served as the ...
(Date:8/29/2014)... JORDAN, Utah , Aug. 29, 2014  BC ... Solutions, has acquired Polaris Medical Imaging, a leader in ... scanners. This strategic acquisition allows BC Technical to continue ... capabilities, specifically within MR and CT modalities. ... cost service," said Mark Alvarez , president and ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2BC Technical Acquires Polaris Medical Imaging 2
... Sept. 7 Symmetry Medical Inc. (NYSE: ... the global orthopedic device industry and other medical markets, ... and Chief Financial Officer, is scheduled to present at ... at the Stifel Nicolaus 2010 Healthcare Conference in Boston, ...
... MORRISTOWN, N.J., Sept. 7 Watson Pharmaceuticals, Inc. (NYSE: ... Watson Laboratories, Inc., has received approval from the United ... New Drug Application (ANDA) for Zarah™ (drospirenone and ethinyl ... Bayer,s Yasmin ® . Watson has begun shipping the ...
Cached Medicine Technology:Symmetry Medical to Present at Two Upcoming Conferences 2Watson's Generic Yasmin® Receives FDA Approval 2
(Date:8/30/2014)... Colorado (PRWEB) August 30, 2014 Daily ... method that keeps anxiety and panic attacks under control ... "Panic Away" program review describes this new method ... sufferers control panic attacks and overcome general anxiety related ... and successful is the fact that it can be ...
(Date:8/30/2014)... Plains, NJ (PRWEB) August 30, 2014 ... first facilities in New Jersey and even in the ... technology that takes inches off of patients’ waists with ... freezing cells in small sections, Vanquish is more inclusive ... pain. Patients lay comfortably under panels about one ...
(Date:8/30/2014)... RB SEO Services, a well-recognized internet ... small businesses. , RBSEO Services knows this very well ... engine optimization service. So, the company has introduced this ... , On being asked about the service, a ... cost SEO service because many small businesses expressed their ...
(Date:8/30/2014)... The establishment and creation of Ideal ... of the main strategies of the Church of ... around the world. , Architecturally stellar buildings with ... and trainers deliver L. Ron Hubbard's spiritual technology ... demonstrate that significant reduction in crime, major decrease ...
(Date:8/30/2014)... August 30, 2014 Acne is a common problem ... acne is nothing more than a daily nuisance, for some, it ... cases of acne can even lead to dramatic mood swings and ... try anything to clear up their skin. In some cases, that ... money through trial and error, those on a quest for clearer ...
Breaking Medicine News(10 mins):Health News:Panic Away Review Reveals New Natural Remedy for Anxiety Patients 2Health News:NJ Top Docs Presents, The Plastic Surgery Group 2Health News:RBSEO Services Introduces Low Cost SEO Service for Small Businesses 2Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Acne Treatment Reviews Added to Popular Treatment Website 2
... Makes Programs More Affordable, WASHINGTON, April 7, ... policies managed by the Department,of Veterans Affairs (VA) ... to,improved investment earnings and a reduction in non-combat ... covered by Servicemembers,Group Life Insurance (SGLI) and veterans ...
... to protect the spinal cord from toxins may play a ... as ALS or Lou Gehrigs disease, according to research published ... mark the first time that scientists have witnessed molecular changes ... finding opens up a new front in studies of ALS, ...
... Renowned doctor and former Attending Physician to Congress is the latest ... addition to the expert team at ... doctor evaluation service listing more than 700,000 active U.S.,doctors, today announced ... independent advisor. Dr. Krasner will lend his expertise to,identify innovative ways ...
... for Intelligence Analysis Program, SAN DIEGO and ... Corporation (NYSE: SAI ) today announced,it was ... Defense Intelligence,Agency (DIA). This multiple-award, indefinite-delivery/indefinite-quantity,contract will support ... dollar value for all task orders that can ...
... interfere with family time, grades and nutrition, study finds , ... may poignantly plead that he or she is the ... health experts recommend that parents stand their ground and keep ... be a good reason for this. The latest research, published ...
... and Features Similar to, Market-Leading Systems in an Easy-to-Use, Accessible and Affordable Format ... ... at the Accuri Booth at ... April 7, 2008 Accuri Cytometers, Inc.,today announced the commercial launch of the Accuri C6 ...
Cached Medicine News:Health News:VA Announces SGLI and VGLI Premium Reductions 2Health News:Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease 2Health News:Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease 3Health News:Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease 4Health News:Dr. Robert CJ Krasner Appointed to Vitals.com as Independent Advisor 2Health News:SAIC Awarded DIA Intelligence Analysis Contract 2Health News:TV in the Bedroom Is Not a Teen's Best Friend 2Health News:TV in the Bedroom Is Not a Teen's Best Friend 3Health News:Accuri Cytometers Announces Commercial Launch of Revolutionary Accuri C6 Flow Cytometer(TM) System 2Health News:Accuri Cytometers Announces Commercial Launch of Revolutionary Accuri C6 Flow Cytometer(TM) System 3Health News:Accuri Cytometers Announces Commercial Launch of Revolutionary Accuri C6 Flow Cytometer(TM) System 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: